Ophthalmology

Gene therapy shows promise in glaucoma research

Pete Williams is one of few researchers in Sweden concentrating on glaucoma. The goal is an effective treatment, something that stops the degenerative process in the nerve cells of the eye.

Medications

FDA approves drug targeting brain cancer gene mutation

A new drug for treatment of a type of brain cancer, called IDH-mutant low-grade glioma, was approved Aug. 6 by the U.S. Food and Drug Administration (FDA). The promising new drug stems from a 2008 genetic discovery made at ...

Inflammatory disorders

Rare metabolic disorder can cause liver inflammation

Millions of people worldwide suffer from liver inflammation (hepatitis), an acute or chronic disease with a variety of causes. Liver inflammation frequently occurs in connection with metabolic disorders, for example fatty ...

page 3 from 40